甲氨蝶呤钠,CAS 登记号 15475-56-6,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于无机化学品。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。
无机化学品
每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。
本页已列出 甲氨蝶呤钠 的 CAS 号:15475-56-6,可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。
主要涉及无机化学品。
来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。
Methotrexate sodium · CAS 15475-56-6 · C20H20N8Na2O5. UNII 3IG1E710ZN.
| CAS Registry Number | 15475-56-6 |
|---|---|
| PubChem CID | 11329481 |
| Molecular formula | C20H20N8Na2O5 |
| IUPAC name | disodium;(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioate |
| UNII (FDA) | 3IG1E710ZN |
| Molecular Weight | 498.4 |
|---|---|
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 7 |
| Exact Mass | 498.13520433 |
| Monoisotopic Mass | 498.13520433 |
| Topological Polar Surface Area | 216 |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 693 |
| Reported hazard statements | H301 (100%), H311 (98.1%), H315 (100%), H319 (100%), H331 (98.1%), H335 (98.1%), H340 (98.1%), H360 (100%) |
|---|
H301 (100%): Toxic if swallowed [Danger Acute toxicity, oral]
H311 (98.1%): Toxic in contact with skin [Danger Acute toxicity, dermal]
Methotrexate disodium salt; 7413-34-5; METHOTREXATE SODIUM; Sodium methotrexate; Disodium methotrexate; Abitrexate; Trexall; Methotrexate Lpf; Folex Pfs; Mexate-Aq Preserved; Mexate-Aq; Methotrexate sodium salt; Methotrexate, Sodium Salt; Methotrexate (as disodium); ADX-2191 SODIUM; Methotrexate Preservative Free
CAS 15475-56-6; molecular formula C20H20N8Na2O5; molecular weight — g/mol.
Methotrexate disodium salt, 7413-34-5, METHOTREXATE SODIUM, Sodium methotrexate, Disodium methotrexate, Abitrexate.
Hazard statements reported: H301, H311, H315, H319, H331.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.